Literature DB >> 32965517

Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer.

Hyungin Park1, Seung Ho Kim2, Yedaun Lee1, Jung Hee Son1.   

Abstract

PURPOSE: To compare the diagnostic performance between diffusion kurtosis imaging (DKI) parameters and mono-exponential apparent diffusion coefficient (ADC) for determination of clinically significant cancer (CSC, Gleason score (GS) ≥ 7) in patients with histologically proven prostate cancer (PCa).
METHODS: A total of 92 patients (mean age: 71.5 years, range: 47-89 years) who had been diagnosed as PCa and undergone 3 T-MRI including DWI (b values, 0, 100, 1000, 2000s/mm2) were included in this study. The DKI parameters, namely apparent diffusion for non-Gaussian distribution (Dapp) and apparent kurtosis coefficient (Kapp), were calculated by dedicated software using mono-exponential and diffusion kurtosis models for quantitation. The measurement was performed for a whole tumor after segmentation, and pathologic topographic maps or systemic biopsy results served as the reference standard for segmentation. To compare the diagnostic performance of each parameter for determination of CSC, pair-wise comparison of receiver operating characteristic (ROC) curves was performed.
RESULTS: The study population consisted of GS 6 (n = 18), GS 7 (n = 31), GS 8 (n = 25), GS 9 (n = 15) and GS 10 (n = 3) patients. The area under the ROC curve of Kapp (0.707, 95% CI 0.603-0.798) for discriminating CSC from non-CSC was not significantly different from those of mono-exponential ADC (0.725, 0.622-0.813, P = 0.2175) or Dapp (0.726, 0.623-0.814, P = 0.9628). Diagnostic predictive values of Kapp were estimated to a maximum accuracy of 78%, a sensitivity of 86%, and a specificity of 47%, while those of mono-exponential ADC were 75, 81, and 53%, respectively.
CONCLUSION: The DKI parameters showed a diagnostic performance comparable to mono-exponential ADC for determination of CSC in patients with PCa.

Entities:  

Keywords:  Diffusion kurtosis imaging (DKI); Gleason score; Magnetic resonance imaging (MRI); Prostate cancer; Risk assessment

Mesh:

Year:  2020        PMID: 32965517     DOI: 10.1007/s00261-020-02776-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer.

Authors:  Hyungin Park; Seung Ho Kim; Joo Yeon Kim
Journal:  Quant Imaging Med Surg       Date:  2022-01

Review 2.  Diffusion-Weighted MRI in the Genitourinary System.

Authors:  Thomas De Perrot; Christine Sadjo Zoua; Carl G Glessgen; Diomidis Botsikas; Lena Berchtold; Rares Salomir; Sophie De Seigneux; Harriet C Thoeny; Jean-Paul Vallée
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

3.  Comparison of the Differential Diagnostic Performance of Intravoxel Incoherent Motion Imaging and Diffusion Kurtosis Imaging in Malignant and Benign Thyroid Nodules.

Authors:  Liling Jiang; Jiao Chen; Haiping Huang; Jian Wu; Junbin Zhang; Xiaosong Lan; Daihong Liu; Jiuquan Zhang
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

4.  Using IVIM Parameters to Differentiate Prostate Cancer and Contralateral Normal Tissue through Fusion of MRI Images with Whole-Mount Pathology Specimen Images by Control Point Registration Method.

Authors:  Cheng-Chun Lee; Kuang-Hsi Chang; Feng-Mao Chiu; Yen-Chuan Ou; Jen-I Hwang; Kuan-Chun Hsueh; Hueng-Chuen Fan
Journal:  Diagnostics (Basel)       Date:  2021-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.